Topiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: a case-report
- PMID: 19171058
- PMCID: PMC2637258
- DOI: 10.1186/1757-1626-2-87
Topiramate-associated acute glaucoma in a migraine patient receiving concomitant citalopram therapy: a case-report
Abstract
We describe the case of a 34 year-old man with diagnosis of migraine with and without aura that developed myopia and acute glaucoma after 7 days of treatment with topiramate. The patient had also been taking citalopram daily for two months. Both topiramate and citalopram have been related to the increase of intraocular pressure and the development of glaucoma. We can't exclude that in this patient citalopram caused an increase of the ocular pressure in dose-dependent manner, facilitating topiramate-induced glaucoma. We recommend to pay particular attention in prescribing of topiramate in migraine patients who are already under treatment with citalopram or other antidepressants with a similar mechanisms of action.
References
-
- Pascual J, Sánchez del Rio M, Mateos V, Láinez JM, Hernández-Gallego J, Leira R. Topiramate for patients with refractory migraine: an observational, multicentre study in Spain. Neurology. 2003;18:364–367. - PubMed
-
- Spina E, Perugi G. Antiepileptic drugs: indications other than epilepsy. Epileptic Disord. 2004;6:57–75. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
